Brief: Invo Bioscience Inc Says Revenue For The Year Ended December 31, 2022 Is Expected To Decrease By About 80% In 2022 As Compared To 2021 - Filing

INVO Fertility

30/03/2023 22:48

March 30 (Reuters) - INVO Bioscience Inc  INVO.O :
    * INVO BIOSCIENCE INC FILES FOR NON TIMELY 10-K WITH U.S.
SEC
    * INVO BIOSCIENCE INC - REVENUE FOR THE YEAR ENDED DECEMBER
31,
2022 IS EXPECTED TO DECREASE BY ABOUT 80% IN 2022 AS COMPARED TO
2021
    * INVO BIOSCIENCE INC - EXPECTS TO FILE THE FORM 10-K WITHIN
THE
EXTENSION PERIOD OF 15 CALENDAR DAYS.

Further company coverage:  INVO.O 

 ((Reuters.Briefs@thomsonreuters.com;;))